Related Experiment Video
Updated: Jul 31, 2025

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.2K
Developing and Validating a Prediction Model For Death or Critical Illness in Hospitalized Adults, an Opportunity for
Amol A Verma1,2,3, Chloe Pou-Prom1, Liam G McCoy2
1St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Critical Care Explorations
|May 8, 2023
Summary
Machine learning models can predict patient deterioration with clinician-level accuracy. Combining AI and human judgment improves early detection of critical events in hospitals.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Clinical Decision Support
Background:
- Hospital early warning systems increasingly use machine learning (ML) to predict clinical deterioration.
- The complementary role of ML predictions with physician and nurse judgment is not well understood.
Purpose of the Study:
- To train and validate an ML model for predicting patient deterioration.
- To compare ML model predictions with real-world physician and nurse predictions.
Main Methods:
- Developed and validated a neural network model using retrospective data (April 2011-April 2019).
- Compared ML predictions with prospective clinician predictions (nurses, residents, attending physicians) in a cohort study (April-August 2019).
Main Results:
- ML model achieved clinician-level accuracy for predicting in-hospital death and ICU admission (AUC 0.77 vs. 0.64).
- ML predictions were more accurate than clinicians for ICU admission.
- Combining human and ML predictions detected 49% of clinical deterioration events, improving sensitivity by 16% compared to clinicians alone.
Conclusions:
- ML models can effectively complement clinician judgment in predicting hospital patient deterioration.
- Human-computer collaboration offers significant potential for improving prognostication and personalized medicine.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
232
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
232
Assumptions of Survival Analysis
163
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
163
Cancer Survival Analysis
405
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
405
Actuarial Approach
101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101
Introduction To Survival Analysis
303
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
303
Kaplan-Meier Approach
201
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
201

